RxDoctor Payments Data

Kevin Kopko, MD

Adult Reconstructive Orthopaedic Surgery · Syracuse, NYNPI 1700102928

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Stryker at 36.9% of the total.

$33,505in general payments, 2019–2025

Across 304 payments — averaging $110.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$12K
  • Smith+Nephew$9K
  • Lima USA, Inc.$8K
  • Encore Medical, LP$2K
  • Zimmer Biomet$466
  • Limacorporate S.p.a.$435
  • plus $927 from 7 others
$20,655in research payments, 2019–2025

Across 8 payments — averaging $2581.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$20K
  • Smith+Nephew$500

What the payments were for

  • Consulting fees$7,54223%
  • Travel & lodging$13,78541%
  • Food & beverage$12,17836%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,505 in reported general payments places this provider in the 70th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$326,858
Medicare patients
802
Services billed
20,976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib172$2,366
Cephalexin64$1,528
Naloxone Hcl12$1,082
Meloxicam330$716
Ketorolac Tromethamine73$561
Tramadol Hcl170$463
Oxycodone Hcl43$239
Methylprednisolone40$199
Amoxicillin205$194
Ondansetron OdtOndansetron13$58
Azithromycin52$48

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →